Trade

with

Regulus Therapeutics Inc
(NASDAQ: RGLS)
AdChoices
13.75
+6.98
+103.10%
Pre-Market :
14.19
+0.44
+3.20%

Open

14.56

Previous Close

6.77

Volume (Avg)

20.31M (371.09k)

Day's Range

11.13-15.38

52Wk Range

5.40-15.38

Market Cap.

596.64M

Dividend Rate ( Yield )

-

Beta

-

Shares Outstanding

43.39M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 19.57M

    • Net Income

    • -18.67M

    • Market Cap.

    • 596.64M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -206.65

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • -

    • Forward P/E

    • -6.91

    • Price/Sales

    • 20.41

    • Price/Book Value

    • 3.58

    • Price/Cash flow

    • -8.45

      • EBITDA

      • -17.30M

      • Return on Capital %

      • -27.91

      • Return on Equity %

      • -43.84

      • Return on Assets %

      • -27.91

      • Book Value/Share

      • 1.89

      • Shares Outstanding

      • 43.39M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 19.00

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • -0.97

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -84.50

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 100.00

            • 82.75

            • Pre-Tax Margin

            • -206.82

            • 39.38

            • Net Profit Margin

            • -206.65

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.15

              • 0.76

              • Current Ratio

              • 9.58

              • 2.92

              • Quick Ratio

              • 9.19

              • 2.35

              • Interest Coverage

              • -738.18

              • 38.02

              • Leverage Ratio

              • 1.39

              • 2.21

              • Book Value/Share

              • 1.89

              • 4.75

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -9.62

                • 277.78

                • P/E Ratio 5-Year High

                • -18.81

                • 634.30

                • P/E Ratio 5-Year Low

                • -5.87

                • 124.82

                • Price/Sales Ratio

                • 19.88

                • 9.35

                • Price/Book Value

                • 3.48

                • 8.50

                • Price/Cash Flow Ratio

                • -8.45

                • 50.25

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -43.84

                        (-)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • -27.91

                        (-)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • -36.31

                        (-)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • -

                      • 117.08k

                      • Inventory Turnover

                      • -

                      • 1.48

                      • Asset Turnover

                      • 0.14

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -17.80M
                      Operating Margin
                      -90.97
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -8.45
                      Ownership

                      Institutional Ownership

                      94.59%

                      Top 10 Institutions

                      85.36%

                      Mutual Fund Ownership

                      23.29%

                      Float

                      28.29%

                      5% / Insider Ownership

                      0.19%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Fidelity® Growth Company Fund

                      •  

                        2,930,181

                      • 0.00

                      • 6.75

                      • Fidelity® Select Biotechnology Portfolio

                      •  

                        1,746,479

                      • 13.62

                      • 4.02

                      • Fidelity® Series Growth Company Fund

                      •  

                        703,400

                      • 0.00

                      • 1.62

                      • Goldman Sachs Small/Mid Cap Growth Fund

                      •  

                        701,703

                      • -3.38

                      • 1.62

                      • iShares Nasdaq Biotechnology

                      •  

                        576,011

                      • -0.69

                      • 1.33

                      • Fidelity Advisor® Growth Opportunities

                      •  

                        337,200

                      • 0.00

                      • 0.78

                      • T. Rowe Price New America Growth Fund

                      •  

                        322,900

                      • 0.00

                      • 0.74

                      • Prudential Jennison Health Sciences

                      •  

                        319,659

                      • 0.00

                      • 0.74

                      • Vanguard Total Stock Mkt Idx

                      •  

                        287,819

                      • 0.00

                      • 0.66

                      • Fidelity Advisor® Biotechnology Fund

                      •  

                        225,391

                      • 21.43

                      • 0.52

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Isis Pharmaceuticals Inc

                      •  

                        7,049,500

                      • 0.00%

                      • 16.33

                      • Fidelity Management and Research Company

                      •  

                        6,317,134

                      • +0.04%

                      • 14.56

                      • Alnylam Pharmaceuticals Inc

                      •  

                        6,150,500

                      • 0.00%

                      • 14.25

                      • Sanofi

                      •  

                        5,053,779

                      • +34.77%

                      • 11.71

                      • GlaxoSmithKline PLC

                      •  

                        1,947,037

                      • -41.51%

                      • 4.51

                      • Healthcor Management, L.p.

                      •  

                        1,550,000

                      • -1.59%

                      • 3.57

                      • Wellington Management Company, LLP

                      •  

                        940,070

                      • +26.19%

                      • 2.17

                      • BlackRock Fund Advisors

                      •  

                        849,286

                      • +4.05%

                      • 1.96

                      • Goldman Sachs Asset Management, L.P.

                      •  

                        791,207

                      • +0.87%

                      • 1.82

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Speculative Growth

                      Style

                      -

                      Regulus Therapeutics Inc is a biopharmaceutical company. The Company is engaged in discovering & developing drugs that target micro RNAs to treat a range of diseases.

                      Key People

                      Dr. Kleanthis G. Xanthopoulos,PhD

                      CEO/Director/President

                      Dr. Stelios Papadopoulos,PhD

                      Chairman of the Board/Director

                      Ms. B. Lynne Parshall, J.D.

                      Director

                      Dr. Bruce L.A. Carter,PhD

                      Director

                      Dr. Douglas E. Williams,PhD

                      Director

                      • Regulus Therapeutics Inc

                      • 3545 John Hopkins Court

                      • San Diego, CA 92121

                      • USA.Map

                      • Phone: +1 858 202-6300

                      • Fax: -

                      • regulusrx.com

                      Incorporated

                      2007

                      Employees

                      76

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: